- Home
- AZZ vs VCYT Comparison
AZZ vs VCYT Comparison
Compare AZZ & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZZ
- VCYT
- Stock Information
- Founded
- AZZ 1956
- VCYT 2006
- Country
- AZZ United States
- VCYT United States
- Employees
- AZZ N/A
- VCYT N/A
- Industry
- AZZ Industrial Specialties
- VCYT Medical Specialities
- Sector
- AZZ Industrials
- VCYT Health Care
- Exchange
- AZZ Nasdaq
- VCYT Nasdaq
- Market Cap
- AZZ 3.0B
- VCYT 2.9B
- IPO Year
- AZZ N/A
- VCYT 2013
- Fundamental
- Price
- AZZ $107.21
- VCYT $48.53
- Analyst Decision
- AZZ Buy
- VCYT Buy
- Analyst Count
- AZZ 7
- VCYT 9
- Target Price
- AZZ $115.43
- VCYT $43.56
- AVG Volume (30 Days)
- AZZ 232.7K
- VCYT 1.2M
- Earning Date
- AZZ 01-06-2026
- VCYT 11-04-2025
- Dividend Yield
- AZZ 0.76%
- VCYT N/A
- EPS Growth
- AZZ 855.67
- VCYT N/A
- EPS
- AZZ 10.37
- VCYT 0.38
- Revenue
- AZZ $1,594,766,000.00
- VCYT $495,141,000.00
- Revenue This Year
- AZZ $5.28
- VCYT $14.52
- Revenue Next Year
- AZZ $5.12
- VCYT $9.90
- P/E Ratio
- AZZ $10.19
- VCYT $125.41
- Revenue Growth
- AZZ 1.55
- VCYT 16.41
- 52 Week Low
- AZZ $70.90
- VCYT $22.61
- 52 Week High
- AZZ $119.95
- VCYT $50.71
- Technical
- Relative Strength Index (RSI)
- AZZ 64.43
- VCYT 71.15
- Support Level
- AZZ $98.00
- VCYT $37.98
- Resistance Level
- AZZ $99.89
- VCYT $50.71
- Average True Range (ATR)
- AZZ 2.91
- VCYT 2.11
- MACD
- AZZ 1.06
- VCYT 0.73
- Stochastic Oscillator
- AZZ 94.07
- VCYT 82.09
About AZZ AZZ Inc.
AZZ Inc is a provider of galvanizing and a variety of metal coating solutions and coil coating solutions to a broad range of end markets in North America. The company's operating segment consists of Metal Coatings, Precoat Metals, and Infrastructure Solutions. The company generates the majority of its revenue from the Precoat Metals segment, which provides coil coating application of protective and decorative coatings and related value-added downstream processing for steel and aluminum coils. Geographically, the company generates the majority of its revenue from the United States.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.